Genotype-phenotype correlations in laminopathies: how does fate translate?
- PMID: 20074070
- DOI: 10.1042/BST0380257
Genotype-phenotype correlations in laminopathies: how does fate translate?
Abstract
A-type laminopathies are a group of diseases resulting from mutations in the intermediate filament proteins lamin A and C (both encoded by the LMNA gene), but for which the pathogenic mechanisms are little understood. In some laminopathies, there is a good correlation between the presence of a specific LMNA mutation and the disease diagnosed. In others however, many different mutations can give rise to the same clinical condition, even though the mutations may be distributed throughout one, or more, of the three functionally distinct protein domains of lamin A/C. Conversely, certain mutations can cause multiple laminopathies, with related patients carrying an identical mutation even having separate diseases, often affecting different tissues. Therefore clarifying genotype-phenotype links may provide important insights into both disease penetrance and mechanism. In the present paper, we review recent developments in genotype-phenotype correlations in laminopathies and discuss the factors that could influence pathology.
Similar articles
-
The laminopathies: a clinical review.Clin Genet. 2006 Oct;70(4):261-74. doi: 10.1111/j.1399-0004.2006.00677.x. Clin Genet. 2006. PMID: 16965317 Review.
-
[Laminopathies: one gene, several diseases].Biol Aujourdhui. 2011;205(3):147-62. doi: 10.1051/jbio/2011017. Epub 2011 Oct 11. Biol Aujourdhui. 2011. PMID: 21982404 Review. French.
-
[The role of lamins and mutations of LMNA gene in physiological and premature aging].Postepy Biochem. 2007;53(1):46-52. Postepy Biochem. 2007. PMID: 17718387 Review. Polish.
-
Nesprin-2 giant safeguards nuclear envelope architecture in LMNA S143F progeria cells.Hum Mol Genet. 2007 Dec 1;16(23):2944-59. doi: 10.1093/hmg/ddm255. Epub 2007 Sep 19. Hum Mol Genet. 2007. PMID: 17881656
-
Nuclear envelope proteins and chromatin arrangement: a pathogenic mechanism for laminopathies.Eur J Histochem. 2006 Jan-Mar;50(1):1-8. Eur J Histochem. 2006. PMID: 16584978 Review.
Cited by
-
Epigenetic alterations in muscular disorders.Comp Funct Genomics. 2012;2012:256892. doi: 10.1155/2012/256892. Epub 2012 Jun 18. Comp Funct Genomics. 2012. PMID: 22761545 Free PMC article.
-
Deciphering the Clinical Presentations in LMNA-related Lipodystrophy: Report of 115 Cases and a Systematic Review.J Clin Endocrinol Metab. 2024 Feb 20;109(3):e1204-e1224. doi: 10.1210/clinem/dgad606. J Clin Endocrinol Metab. 2024. PMID: 37843397 Free PMC article.
-
Genotype-phenotype analysis of LMNA-related diseases predicts phenotype-selective alterations in lamin phosphorylation.FASEB J. 2020 Jul;34(7):9051-9073. doi: 10.1096/fj.202000500R. Epub 2020 May 15. FASEB J. 2020. PMID: 32413188 Free PMC article.
-
Limb-girdle muscular dystrophies: where next after six decades from the first proposal (Review).Mol Med Rep. 2014 May;9(5):1515-32. doi: 10.3892/mmr.2014.2048. Epub 2014 Mar 13. Mol Med Rep. 2014. PMID: 24626787 Free PMC article. Review.
-
Ameliorating pathogenesis by removing an exon containing a missense mutation: a potential exon-skipping therapy for laminopathies.Gene Ther. 2015 Jun;22(6):503-15. doi: 10.1038/gt.2015.8. Epub 2015 Apr 2. Gene Ther. 2015. PMID: 25832542
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous